Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Poolbeg Pharma plc
Headquarters: United Kingdom
Website: https://www.poolbegpharma.com/...
Year Founded: 2021
Status: Public
Industry Sector: HealthTechnology
CEO: Jeremy Skillington, PhD
Number Of Employees: N/A
Enterprise Value: $42,113,746
PE Ratio: -3.24
Exchange/Ticker 1: LSE:POLB
Exchange/Ticker 2: N/A
Latest Market Cap: $18,416,206
BioCentury | Jan 7, 2025
Deals
Irish sale from Wuxi Biologics, Roche looks to Innovent for ADC
BioCentury’s Deals Report: Wuxi Biologics, Hutchmed in asset sales and more
BioCentury | Nov 10, 2023
Management Tracks
New CFO, CMO at TreeFrog
Plus: Metagenomi names Borges CSO and Wapnick CFO, and updates from Teva, Century, Assembly and more
BioCentury | May 15, 2023
Product Development
Fundraising struggles, an LSE surprise and Ireland’s burgeoning biotech ecosystem
Takeaways from Bio€quity Europe on the latest BioCentury This Week
BioCentury | Jul 21, 2021
Deals
July 20 Quick Takes: PacBio in $600M takeout of Omniome
Plus: C round for Amylyx, Longitude fund, approval for Albireo, Hong Kong IPO queue and more
Items per page:
1 - 4 of 4